← Open Payments lookup

COLIN AMINKENG: Open Payments

NPI 1194208181 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,571 in 91 payments from 11 companies in 2025. Trend: 2023 $1,050 · 2024 $1,156 · 2025 $1,571

Food & beverage: $1,571
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.20$335
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)19$277
Teva Pharmaceuticals USA, Inc.21$240
Alkermes, Inc.11$223
Otsuka America Pharmaceutical, Inc.4$154
Lundbeck LLC5$93
Vanda Pharmaceuticals Inc.3$73
ABBVIE INC.3$72
Janssen Pharmaceuticals, Inc2$54
Neurocrine BioSciences, Inc.2$34

Products named: COBENFY, CAPLYTA, ABILIFY ASIMTUFII, UZEDY, ARISTADA, LYBALVI, FANAPT, VRAYLAR.

Industry payments across TX — which companies pay providers there.